Publication

P105. How end of treatment nursing consultations continued via telephone due to COVID-19

Scarrott, Sue
Mannings, Sarah
Degaris, Lucy
Date
2021-05-04
Type
Conference Abstract
Engagement
Google Scholar:
Altmetric:
Collections
Abstract
Introduction: Thirlestaine Breast Centre (TBC) in Gloucestershire diagnoses approximately 700 breast cancers per annum. The Recovery Package is a recognised national programme to assist people living with and beyond a cancer diagnosis, to live well. As nurses, we are directly involved with all four components - Holistic Needs Assessment, Care and Support Planning, Treatment Summary (End of Treatment Consultations) and Health and Wellbeing events. These were face to face appointments until Covid-19 impacted. Methods: TBC commenced treatment summaries in April 2018, alongside a health and wellbeing event. Due to staff redeployment for Covid, few summaries were undertaken early on in the pandemic and a catch up was required. Since May 2020, again due to Covid, these end of treatment consultations have been completed as telephone appointments. Our end of treatment consultations are recorded on Infoflex and a new template was introduced in October 2020, which provides an opportunity for patient feedback. Results: Since May 2020, 489 telephone end of treatment consultations have taken place and we have received 34 patient feedback forms since October. Feedback is very positive - 'I felt more comfortable to discuss worries as I was at home', 'it didn't feel rushed', staff are 'all very kind and caring'. Conclusions: Our nursing experience of undertaking end of treatment consultations via telephone, has clearly demonstrated that patients have appreciated their consultations taking place, whilst enabling them to stay safe at home. Due to this being positively received, we are now continuing these by phone.
Citation
Scarrott, S., Mannings, S., & Degaris, L. (2021). P105. How end of treatment nursing consultations continued via telephone due to COVID-19. European Journal of Surgical Oncology, 47(5), e323–e324. https://doi.org/10.1016/j.ejso.2021.03.109
Registration number
License
Usage rights
License